Use of Neoadjuvant Endocrine Therapy Showcases Testing Capabilities in Breast Cancer
October 6th 2019
In breast cancer, neoadjuvant endocrine therapy shows promise in a variety of areas, including as an excellent testing platform, Ingrid A. Mayer, MD, MSCI, said in a presentation during the 2019 Lynn Sage Breast Cancer Symposium.